All News

Jonathan Hausmann MD Tweet
hausmannMD
Treatment of patients with haploinsufficiency 20 (HA20) responds to HIGH (500mg!) doses of anakinra, TNF inhibitors, or--recently--JAK inhibitors. @AmandaOmbrello #ACR19 @RheumNow
Jonathan Hausmann MD Tweet
hausmannMD

The questions that Dr. Amanda Ombrello (@NIH) asks when evaluating patients with recurrent fevers: -Age of onset -Frequency -Duration -Regularity -Height of fever -Prodromal symptoms #ACR19 @rheumnow

Gout Study Group Tweet
GoutGroup
Can lowering #uricacid improve hepatic fibrosis? Dr Naomi Schlesinger presented data from pegloticase #gout studies showing improvement/prevention of worsening vs pbo via the Fib-4 score Changes esp marked in pts with clinically important baseline Fib-4 score @RheumNow #ACR2019 https://t.co/8QUZvlcf57
Maeve Gamble Tweet
MaeveGamble
“It’s so rare that a lupus clinical trial makes it to a plenary session...so cherish the moment!” -Dr Richard Furie on anifrolumab in SLE 🤣 #ACR19 @RheumNow
Mike Putman Tweet
EBRheum
TULIP1 Anifrolumab RCT in SLE Did NOT meet primary endpt SIR4 wk52 (36% v 40% PLBO, NS) Post Hoc BICLA response DID favor Tx (46% v 30%, NNT~6) Richard Furie: "Medication rules and endpoint selection are critical for SLE trials." Agreed. #ACR19 Abst#1763 #ACRBest @RheumNow https://t.co/R4ily1Ubrz
David Liew Tweet
drdavidliew
Neonatal complete heart block is one to avoid. In Ro-pos mothers with a prev child with CHB, HCQ reduces rates from a historic 20% to 7.4% in the PATCH study. It seems we’re yet to fully realize the power of HCQ in conditions like these! @nyuschoolofmed #ACR19 ABST1761 @RheumNow https://t.co/TMzmq6TjJx
Olga Petryna Tweet
DrPetryna
#ACR19 @Rheumnow ABS1217 pegadricase (0.2 mg/kg) +ImmTOR (0.15 mg/kg) selected for HtoH study of SEL-212 vs pegloticase based on Ph2T result showing addition of ImmTOR at ≥0.1 mg/kg ⬇️ ADA formation & 66% of pts maintained sUA levels < 6 mg/dL at Wk20.
Dr. John Cush Tweet
RheumNow
Over the last 10 years racial and ethnic minorities are significantly underrepresented in rheumatoid arthritis clinical trials with no hope for improvement in the future. How applicable are these results when they do not reflect the population? #ACR19 abstract# 1160 https://t.co/WNSGfyCSKu
Dr. John Cush Tweet
RheumNow
RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Horizon Therapeutics. All content chosen by RheumNow and its faculty.
k dao Tweet
KDAO2011
#acr19 @rheumnow FDA notes w/Rheum Meds: 1. ⬇️apremilast dose in Apremilast to 30 mg/d for pt with severe CKD 2. Ok to use RTX in kids 2+ years old 3. Maintenance RTX 500 mg x2 the 500 mg q6mo x18 mo after induction Rx for GPA/MPA (kids use 250 mg/m2 dose then 250 mg/m2 q6 mo
Maeve Gamble Tweet
MaeveGamble
Abstr#1758: In pts with MSK symptoms and +antiCCP, those at high risk of developing RA had tenosynovitis, higher levels of IL-6 and ACPAs. #ACR2019 @RheumNow #RA #rheumatoidarthritis
David Liew Tweet
drdavidliew
Some hand OA patients with an inflammatory phenotype have structural benefit from lower dose MTX (but no difference with pain or function, but no difference with adverse events). Why the disconnect? And what’s a rheumatologist to do? Nice, France #ACR19 ABST1759 @RheumNow https://t.co/4SvWzps9DU
Dr. Rachel Tate Tweet
uptoTate
The neutrophil nets take the win with nemaline rod myopathy which an be associated with congenital abnormality or HIV. Knowledge Bowl #ACRbest #ACR19 @RheumNow https://t.co/oIhWrcDUP5
Maeve Gamble Tweet
MaeveGamble
Great discussion on OA today at the Plenary session. #ACR19 @RheumNow What would you try in your erosive OA patients who have failed conservative therapy (hand therapy, analgesics and NSAIDs)?
David Liew Tweet
drdavidliew
@RheumNow What about pred for hand OA? Well PNL 10 has an effect while you're taking it, with reduction of synovial thickening, and in this study was well tolerated. Stop taking it, and you're back to baseline. Leiden #ACR19 ABST 1760 @RheumNow https://t.co/aw4UNHol7J
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×